Physician profile
Cory P Gray
NPI 1598143042
$601.42
in general payments reported to CMS, 2019-2025
16 companies · $202 in 2025
The $202 reported for 2025 was more than what 83% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.21 · 2022: $46.51 · 2023: $54.10 · 2024: $260 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mindray Ds USA, INC. | $144.90 | 2024-2025 | Te X, Te7 Max |
| Stryker Corporation | $86.72 | 2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inari Medical, INC. | $84.36 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| E.R. Squibb & Sons, L.L.C. | $53.50 | 2023-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $33.70 | 2022 | |
| Portola Pharmaceuticals, LLC | $25.91 | 2020 | |
| Boston Scientific Corporation | $24.68 | 2023 | Watchman Flx |
| Ucb, INC. | $22.26 | 2024 | Briviact |
| Astrazeneca Pharmaceuticals LP | $21.53 | 2024 | Andexxa |
| Pfizer INC. | $18.44 | 2025 | |
| Aero US INC | $16.43 | 2024 | Aerogen Solo Nebulizer System, Aerogen Usb Controller System, Aerogen Solo; Aerogen Ultra |
| Bioxcel Therapeutics, INC. | $14.87 | 2023 | Igalmi |
| Mallinckrodt Hospital Products INC. | $14.21 | 2024 | Terlivaz |
| Clinical Technology, INC | $13.80 | 2024 | Vascular Product |
| Csl Behring | $13.30 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $12.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cory Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.